Health Care: Drugs

Sinovac Biotech Ltd. (SVA: NASDAQ)

$4.05 0.07 | 1.76%
06/18/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 49.22M 56.84M 33.40M 84.20M
Cost of Sales 15.97M 17.36M 13.78M 18.52M
Gross Operating Profit 33.24M 39.48M 19.62M 65.68M
Selling, General, and Administrative Expenses 30.81M 22.21M 20.68M 18.25M
Research & Development 17.04M 9.01M 8.64M 4.41M
Operating Income before D & A (EBITDA) -14.61M 8.27M -9.69M 43.03M
Depreciation & Amortization 4.72M 5.20M 4.35M 2.24M
Interest Income 2.37M 1.40M 1.13M 1.30M
Other Income - Net -851.57K 588.57K -1.14M 0.00
Special Income / Charges -1.82M 0.00 1.92M 0.00
Total Income Before Interest Expenses (EBIT) -19.63M 5.05M -12.13M 42.09M
Interest Expense 0.00 384.56K 1.18M 534.46K
Pre-Tax Income -19.63M 4.67M -13.31M 41.55M
Income Taxes -883.90K 5.07M -703.88K 11.14M
Minority Interest -3.90M 445.00K -4.09M 10.45M
Net Income From Continuing Operations -18.75M -399.69K -12.60M 19.96M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -18.75M -399.69K -12.60M 19.96M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -14.85M -844.70K -8.51M 19.96M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -16.93M -399.69K -14.53M 19.96M
Preferred Dividends
Net Income Available To Common -18.75M -399.69K -12.60M 19.96M
Basic EPS from Continuing Ops. -0.27 -0.02 -0.16 0.47
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.27 -0.02 -0.16 0.47
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.27 -0.02 -0.16 0.47
Basic Normalized Net Income/Share -0.24 -0.02 -0.18 0.47
EPS fr Continuing Ops. -0.27 -0.02 -0.16 0.46
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.27 -0.02 -0.16 0.46
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.27 -0.02 -0.16 0.46
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -0.24 -0.02 -0.18 0.46
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SVA

View All

Latest SVA Headlines from TheStreet

More Financial News for SVA

Press Releases for SVA

See All Press Releases

Partner Headlines for SVA

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter